help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujimoto, T.
Right arrow Articles by Strauss, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujimoto, T.
Right arrow Articles by Strauss, J. F., III
(American Journal of Pathology. 2002;160:1495-1502.)
© 2002 American Society for Investigative Pathology


Regular Articles

Induction of the Hyaluronic Acid-Binding Protein, Tumor Necrosis Factor-Stimulated Gene-6, in Cervical Smooth Muscle Cells by Tumor Necrosis Factor-{alpha} and Prostaglandin E2

Toshio Fujimoto*, Rashmin C. Savani*, Michiko Watari*, Anthony J. Day{dagger} and Jerome F. Strauss, III*

From the Center for Research on Reproduction and Women’sHealth,* University of Pennsylvania Medical Center,Philadelphia, Pennsylvania; and the Department ofBiochemistry,{dagger} MRC Immunochemistry Unit,University of Oxford, Oxford, United Kingdom

Immediately before parturition the cervix undergoes striking changes in structure (ripening) that facilitate dilatation and effacement. Cervical ripening shares many features in common with inflammation-associated tissue remodeling, making it a valuable process to explore with respect to the biochemical events in extracellular matrix restructuring. Cervical ripening can be pharmacologically induced with prostaglandin E2 (PGE2). Among the biochemical changes in the cervix at parturition is a marked increase in the hyaluronic acid (HA) content. HA and HA-binding proteins have been implicated in tissue hydration, release of collagenase, and leukocyte migration, but their roles in cervical ripening have not been explored. In the present study we examined the ability of PGE2 to induce expression of the HA-binding protein, tumor necrosis factor-stimulated gene (TSG)-6, in human cervical smooth muscle cells (hCSMCs) and compared the PGE2 response to that of tumor necrosis factor-{alpha} (TNF-{alpha}), an established inducer of TSG-6. TNF-{alpha} stimulated TSG-6 mRNA accumulation in a dose- and time-dependent manner, with the maximal response observed at 10 ng/ml after 6 hours of incubation. PGE2 stimulated TSG-6 mRNA expression, but the magnitude of response was substantially less than that produced by TNF-{alpha}, and it was maximal only after 24 hours of incubation. Quantitative real-time polymerase chain reaction was performed to assess the induction of TSG-6 mRNA and nascent transcripts at 24 hours of treatment. Induction of TSG-6 mRNA and nascent transcripts in response to 10 µmol/L of PGE2 was 5.7-fold and 6.3-fold greater than control values, respectively, whereas TNF-{alpha} (10 ng/ml) induced TSG-6 mRNA and nascent transcripts by 80-fold and 134-fold, respectively. TNF-{alpha} and PGE2 stimulated secretion of TSG-6 into the culture medium as detected by Western blotting. The effects of PGE2 on secretion of TSG-6 were delayed compared to TNF-{alpha}. A 1.3-kb fragment of the human TSG-6 proximal promoter drove luciferase expression in transfected hCSMCs. PGE2 increased TSG-6 promoter activity 1.75-fold. Paradoxically, TNF-{alpha} reduced TSG-6 promoter activity by 50%. We conclude that hCSMCs express the hyaladherin TSG-6; that TSG-6 expression in these cells is regulated by PGE2 as well as proinflammatory cytokines; responses of hCSMCs to TNF-{alpha} and PGE2 are distinct in terms of magnitude and the time course; and PGE2 and TNF-{alpha} exert different effects on the TSG-6 proximal promoter.





This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. He, W. Li, D. Y. Tseng, S. Zhang, S.-Y. Chen, A. J. Day, and S. C. G. Tseng
Biochemical Characterization and Function of Complexes Formed by Hyaluronan and the Heavy Chains of Inter-{alpha}-inhibitor (HC{middle dot}HA) Purified from Extracts of Human Amniotic Membrane
J. Biol. Chem., July 24, 2009; 284(30): 20136 - 20146.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
V. Maina, A. Cotena, A. Doni, M. Nebuloni, F. Pasqualini, C. M. Milner, A. J. Day, A. Mantovani, and C. Garlanda
Coregulation in human leukocytes of the long pentraxin PTX3 and TSG-6
J. Leukoc. Biol., July 1, 2009; 86(1): 123 - 132.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Mahoney, K. Mikecz, T. Ali, G. Mabilleau, D. Benayahu, A. Plaas, C. M. Milner, A. J. Day, and A. Sabokbar
TSG-6 Regulates Bone Remodeling through Inhibition of Osteoblastogenesis and Osteoclast Activation
J. Biol. Chem., September 19, 2008; 283(38): 25952 - 25962.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Forteza, S. M. Casalino-Matsuda, M. E. Monzon, E. Fries, M. S. Rugg, C. M. Milner, and A. J. Day
TSG-6 Potentiates the Antitissue Kallikrein Activity of Inter-{alpha}-inhibitor through Bikunin Release
Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 20 - 31.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Kuznetsova, A. J. Day, D. J. Mahoney, M. S. Rugg, D. F. Mosher, and D. D. Roberts
The N-terminal Module of Thrombospondin-1 Interacts with the Link Domain of TSG-6 and Enhances Its Covalent Association with the Heavy Chains of Inter-{alpha}-trypsin Inhibitor
J. Biol. Chem., September 2, 2005; 280(35): 30899 - 30908.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Mahoney, B. Mulloy, M. J. Forster, C. D. Blundell, E. Fries, C. M Milner, and A. J. Day
Characterization of the Interaction between Tumor Necrosis Factor-stimulated Gene-6 and Heparin: IMPLICATIONS FOR THE INHIBITION OF PLASMIN IN EXTRACELLULAR MATRIX MICROENVIRONMENTS
J. Biol. Chem., July 22, 2005; 280(29): 27044 - 27055.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Rugg, A. C. Willis, D. Mukhopadhyay, V. C. Hascall, E. Fries, C. Fulop, C. M. Milner, and A. J. Day
Characterization of Complexes Formed between TSG-6 and Inter-{alpha}-inhibitor That Act as Intermediates in the Covalent Transfer of Heavy Chains onto Hyaluronan
J. Biol. Chem., July 8, 2005; 280(27): 25674 - 25686.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. D. Blundell, A. Almond, D. J. Mahoney, P. L. DeAngelis, I. D. Campbell, and A. J. Day
Towards a Structure for a TSG-6{middle dot}Hyaluronan Complex by Modeling and NMR Spectroscopy: INSIGHTS INTO OTHER MEMBERS OF THE LINK MODULE SUPERFAMILY
J. Biol. Chem., May 6, 2005; 280(18): 18189 - 18201.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
K. J. Straach, J. M. Shelton, J. A. Richardson, V. C. Hascall, and M. S. Mahendroo
Regulation of hyaluronan expression during cervical ripening
Glycobiology, January 1, 2005; 15(1): 55 - 65.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. W. Ross, J. R. Malayer, J. W. Ritchey, and R. D. Geisert
Characterization of the Interleukin-1{beta} System During Porcine Trophoblastic Elongation and Early Placental Attachment
Biol Reprod, October 1, 2003; 69(4): 1251 - 1259.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. M. Milner and A. J. Day
TSG-6: a multifunctional protein associated with inflammation
J. Cell Sci., May 15, 2003; 116(10): 1863 - 1873.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Getting, D. J. Mahoney, T. Cao, M. S. Rugg, E. Fries, C. M. Milner, M. Perretti, and A. J. Day
The Link Module from Human TSG-6 Inhibits Neutrophil Migration in a Hyaluronan- and Inter-alpha -inhibitor-independent Manner
J. Biol. Chem., December 20, 2002; 277(52): 51068 - 51076.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.